| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Crizotinib |
|---|
| Description | Potent inhibitor of c-MET and anaplastic lymphoma kinase (ALK) (cell IC50 values are 8.0 and 20 nM respectively). Selective for c-MET and ALK against >120 different kinases. Displays antitumor efficacy in multiple tumor models; inhibits c-MET-dependent proliferation, migration and invasion of human tumor cells in vitro. Orally bioavailable. Purity 99%. MW (observed): 450.34 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine. PF 02341066, PF 2341066 |
|---|
| Gene, Accession, CAS # | CAS: 877399-52-5 |
|---|
| Catalog # | 4368/10 |
|---|
| Price | |
|---|
| Order / More Info | Crizotinib from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 21266357, 22660439, 27109105, 29042798 |
|---|
| 產(chǎn)品資料 |
|
|